Conor McNamara
Stock Analyst at RBC Capital
(0.77)
# 3,762
Out of 4,840 analysts
122
Total ratings
21.11%
Success rate
-22%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Sector Perform | $72 → $63 | $48.69 | +29.39% | 9 | May 8, 2025 | |
| HOLX Hologic | Maintains: Sector Perform | $75 → $70 | $62.17 | +12.59% | 10 | May 2, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $409 → $392 | $230.36 | +70.17% | 11 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $409 → $392 | $230.22 | +70.27% | 11 | May 2, 2025 | |
| RGEN Repligen | Maintains: Outperform | $202 → $189 | $122.54 | +54.24% | 11 | Apr 30, 2025 | |
| AVTR Avantor | Maintains: Outperform | $24 → $20 | $13.15 | +52.09% | 7 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $651 → $637 | $403.55 | +57.85% | 14 | Apr 24, 2025 | |
| DHR Danaher | Reiterates: Outperform | $250 | $189.18 | +32.15% | 9 | Apr 23, 2025 | |
| ILMN Illumina | Maintains: Outperform | $128 → $112 | $82.49 | +35.77% | 15 | Apr 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $7 → $4 | $1.34 | +198.51% | 3 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $157.16 | +59.71% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $31.26 | +95.14% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $13 | $2.24 | +481.66% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $2.90 | +141.38% | 4 | Aug 7, 2024 |
Bio-Techne
May 8, 2025
Maintains: Sector Perform
Price Target: $72 → $63
Current: $48.69
Upside: +29.39%
Hologic
May 2, 2025
Maintains: Sector Perform
Price Target: $75 → $70
Current: $62.17
Upside: +12.59%
Bio-Rad Laboratories
May 2, 2025
Maintains: Outperform
Price Target: $409 → $392
Current: $230.36
Upside: +70.17%
Bio-Rad Laboratories
May 2, 2025
Maintains: Outperform
Price Target: $409 → $392
Current: $230.22
Upside: +70.27%
Repligen
Apr 30, 2025
Maintains: Outperform
Price Target: $202 → $189
Current: $122.54
Upside: +54.24%
Avantor
Apr 28, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $13.15
Upside: +52.09%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $403.55
Upside: +57.85%
Danaher
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $189.18
Upside: +32.15%
Illumina
Apr 8, 2025
Maintains: Outperform
Price Target: $128 → $112
Current: $82.49
Upside: +35.77%
OmniAb
Mar 27, 2025
Maintains: Outperform
Price Target: $7 → $4
Current: $1.34
Upside: +198.51%
Mar 13, 2025
Initiates: Outperform
Price Target: $251
Current: $157.16
Upside: +59.71%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $31.26
Upside: +95.14%
Nov 8, 2024
Maintains: Outperform
Price Target: $17 → $13
Current: $2.24
Upside: +481.66%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $2.90
Upside: +141.38%